319 related articles for article (PubMed ID: 26010901)
1. Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking.
Tyndale RF; Zhu AZ; George TP; Cinciripini P; Hawk LW; Schnoll RA; Swan GE; Benowitz NL; Heitjan DF; Lerman C;
PLoS One; 2015; 10(5):e0128109. PubMed ID: 26010901
[TBL] [Abstract][Full Text] [Related]
2. Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokers.
Zhu AZ; Zhou Q; Cox LS; David SP; Ahluwalia JS; Benowitz NL; Tyndale RF
Clin Pharmacol Ther; 2014 Aug; 96(2):256-65. PubMed ID: 24733007
[TBL] [Abstract][Full Text] [Related]
3. CHRNA5-A3-B4 genetic variants alter nicotine intake and interact with tobacco use to influence body weight in Alaska Native tobacco users.
Zhu AZ; Renner CC; Hatsukami DK; Benowitz NL; Tyndale RF
Addiction; 2013 Oct; 108(10):1818-28. PubMed ID: 23692359
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation.
Chen LS; Baker TB; Jorenby D; Piper M; Saccone N; Johnson E; Breslau N; Hatsukami D; Carney RM; Bierut LJ
Drug Alcohol Depend; 2015 Sep; 154():278-82. PubMed ID: 26142345
[TBL] [Abstract][Full Text] [Related]
5. Nicotinic acetylcholine gene cluster CHRNA5-A3-B4 variants influence smoking status in a Bangladeshi population.
Chaity NI; Sultana TN; Hasan MM; Shrabonee II; Nahid NA; Islam MS; Apu MNH
Pharmacol Rep; 2021 Apr; 73(2):574-582. PubMed ID: 33675519
[TBL] [Abstract][Full Text] [Related]
6. Genetic Variant in CHRNA5 and Response to Varenicline and Combination Nicotine Replacement in a Randomized Placebo-Controlled Trial.
Chen LS; Baker TB; Miller JP; Bray M; Smock N; Chen J; Stoneking F; Culverhouse RC; Saccone NL; Amos CI; Carney RM; Jorenby DE; Bierut LJ
Clin Pharmacol Ther; 2020 Dec; 108(6):1315-1325. PubMed ID: 32602170
[TBL] [Abstract][Full Text] [Related]
7. Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women.
Tomaz PRX; Santos JR; Scholz J; Abe TO; Gaya PV; Negrão AB; Krieger JE; Pereira AC; Santos PCJL
BMC Med Genet; 2018 Apr; 19(1):55. PubMed ID: 29621993
[TBL] [Abstract][Full Text] [Related]
8. Contribution of Variants in CHRNA5/A3/B4 Gene Cluster on Chromosome 15 to Tobacco Smoking: From Genetic Association to Mechanism.
Wen L; Jiang K; Yuan W; Cui W; Li MD
Mol Neurobiol; 2016 Jan; 53(1):472-484. PubMed ID: 25471942
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers.
Schuit E; Panagiotou OA; Munafò MR; Bennett DA; Bergen AW; David SP
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011823. PubMed ID: 28884473
[TBL] [Abstract][Full Text] [Related]
10. Smoking Cessation Pharmacotherapy Based on Genetically-Informed Biomarkers: What is the Evidence?
Panagiotou OA; Schuit E; Munafò MR; Bennett DA; Bergen AW; David SP
Nicotine Tob Res; 2019 Aug; 21(9):1289-1293. PubMed ID: 30690475
[TBL] [Abstract][Full Text] [Related]
11. Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy.
Sarginson JE; Killen JD; Lazzeroni LC; Fortmann SP; Ryan HS; Schatzberg AF; Murphy GM
Am J Med Genet B Neuropsychiatr Genet; 2011 Apr; 156B(3):275-84. PubMed ID: 21268243
[TBL] [Abstract][Full Text] [Related]
12. Associations of variants in CHRNA5/A3/B4 gene cluster with smoking behaviors in a Korean population.
Li MD; Yoon D; Lee JY; Han BG; Niu T; Payne TJ; Ma JZ; Park T
PLoS One; 2010 Aug; 5(8):e12183. PubMed ID: 20808433
[TBL] [Abstract][Full Text] [Related]
13. Combined genetic influence of the nicotinic receptor gene cluster CHRNA5/A3/B4 on nicotine dependence.
Lee SH; Ahn WY; Seweryn M; Sadee W
BMC Genomics; 2018 Nov; 19(1):826. PubMed ID: 30453884
[TBL] [Abstract][Full Text] [Related]
14. Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers.
Falcone M; Jepson C; Benowitz N; Bergen AW; Pinto A; Wileyto EP; Baldwin D; Tyndale RF; Lerman C; Ray R
Nicotine Tob Res; 2011 Jun; 13(6):498-503. PubMed ID: 21385908
[TBL] [Abstract][Full Text] [Related]
15. CHRNA5-A3-B4 and DRD2 Genes and Smoking Cessation Throughout Adulthood: A Longitudinal Study of Women.
Jones SK; Alberg AJ; Wallace K; Froeliger B; Carpenter MJ; Wolf BJ
Nicotine Tob Res; 2023 May; 25(6):1164-1173. PubMed ID: 36794842
[TBL] [Abstract][Full Text] [Related]
16. A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction.
Weiss RB; Baker TB; Cannon DS; von Niederhausern A; Dunn DM; Matsunami N; Singh NA; Baird L; Coon H; McMahon WM; Piper ME; Fiore MC; Scholand MB; Connett JE; Kanner RE; Gahring LC; Rogers SW; Hoidal JR; Leppert MF
PLoS Genet; 2008 Jul; 4(7):e1000125. PubMed ID: 18618000
[TBL] [Abstract][Full Text] [Related]
17. CHRNA5 variant predicts smoking cessation in patients with acute myocardial infarction.
Chen LS; Bach RG; Lenzini PA; Spertus JA; Bierut LJ; Cresci S
Nicotine Tob Res; 2014 Sep; 16(9):1224-31. PubMed ID: 24727484
[TBL] [Abstract][Full Text] [Related]
18. Association of CHRNA5-A3-B4 variation with esophageal squamous cell carcinoma risk and smoking behaviors in a Chinese population.
Wang Y; Wu H; Liu Q; Wang C; Fu L; Wang H; Zhu W; Fu W; Lv Y; Wang S; Hu L
PLoS One; 2013; 8(7):e67664. PubMed ID: 23844051
[TBL] [Abstract][Full Text] [Related]
19.
Chaity NI; Apu MNH
Heliyon; 2022 Jul; 8(7):e09947. PubMed ID: 35865987
[TBL] [Abstract][Full Text] [Related]
20. Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk.
Wassenaar CA; Dong Q; Wei Q; Amos CI; Spitz MR; Tyndale RF
J Natl Cancer Inst; 2011 Sep; 103(17):1342-6. PubMed ID: 21747048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
